Over half of insulin pump users and nearly a third of glucose sensor users developed skin issues including eczema, scars, and lipodystrophy in a 1,719-child study. These technologies remain gold-standard care for type 1 diabetes, improving glucose control and quality of life, but access remains unequal in Brazil's public health system.
Notícias Botucatu
· Jun 07, 2026
· health
· 3 min read
High
Sourcing: Verified
Skin complications emerge in children using glucose sensors and insulin pumps
Children with type 1 diabetes experience skin complications from life-saving medical devices, potentially affecting treatment adherence and quality of life.
◉
Science & Space
1332 related articles
NASA announces Artemis III astronaut crew for lunar mission
Google News · 99% match
Nasa anuncia astronautas para Artemis III, missão de teste lunar
Veja · 99% match
SpaceX launches Starship, world's most powerful rocket, resuming tests…
CNN Brasil · 99% match
NASA engineer: Moon settlement comes before Mars in space exploration …
Estadão · 99% match
NASA selects Blue Origin for second lunar lander in Artemis program
Valor Econômico · 90% match
Related Coverage
ICL Notícias · Aug 19
Corpos de dois belgas desaparecidos há 34 anos são encontrados nos Alpes suíços
Restos mortais de dois belgas desaparecidos em 1992 foram encontrados nos Alpes suíços após derretimento de geleira. Des…
Google News · Aug 19 NASA encontra “criatura” misteriosa em Marte e imagem reacende teorias sobre vida fora da Terra - diariodocomercio.com.bImagem de rover da NASA em Marte reaviva especulações sobre possível vida extraterrestre, embora agência não tenha confi…
Diário do Comércio · Aug 19 Imagem de Marte da Nasa reacende teorias sobre vida extraterrestreImagem do robô Curiosity da Nasa em Marte viralizou nas redes sociais com objeto misterioso que internautas associaram a…
CNN Portugal · Aug 19 Satélite da NASA capta cratera de 18 metros causada por foguetão SpaceX na LuaSatélite da NASA captura imagens de uma cratera de 18 metros formada pelo impacto de um andar superior de um foguetão Fa…
Bias & Framing
⚖
Article presents balanced reporting on skin complications from diabetes technology while acknowledging clinical benefits, with expert perspective emphasizing individualized treatment decisions.
Bias Direction
center
Confidence
HIGH
Risk-benefit balance framing: The headline emphasizes complications, but the body text and expert quote contextualize these as manageable side effects outweighed by therapeutic benefits. The opening sentence in the body immediately notes that benefits 'generally outweigh risks,' providing counterbalance.
tornaram frequentes problemas de pele (made skin problems frequent)
padrão-ouro de cuidado (gold standard of care - positive framing for technology)
Voices of affected children/adolescents or parents describing their experiences with skin complications
Dermatologists' perspective on treatment or prevention of these skin issues
Cost-benefit analysis or economic considerations for families
Perspective from patients who discontinued use due to skin problems
Alternative diabetes management approaches and their complication rates for comparison
Geopolitical Impact
🌎
Medical study on pediatric diabetes device side effects has no direct geopolitical implications; findings are healthcare-focused with multinational research collaboration.
Escalation Risk
low
Confidence
HIGH
No power dynamics shifts. This is a clinical research publication involving international medical collaboration (22 centers globally, including Brazil's Unicamp).
Economic Lens
📈
Study reveals 52% of children using insulin pumps experience skin complications, though diabetes control benefits generally outweigh risks, signaling need for improved device design and dermatological support.
Market Signal
mixed
Confidence
HIGH
Medical devices and diabetes technology
Pharmaceutical and insulin manufacturing
Healthcare services and pediatric care
Dermatology and skin care products
Health insurance and medical coverage
Families managing childhood diabetes face trade-offs between improved glucose control and skin health complications. Increased demand for dermatological support and device improvements may raise healthcare costs. Parents may seek alternative treatment options or demand better device designs, affecting purchasing decisions and insurance coverage negotiations.
Regulatory bodies may require enhanced safety labeling and dermatological monitoring protocols for glucose sensors and insulin pumps. Healthcare systems should consider covering preventive skin care and dermatological consultations for pediatric diabetes patients. Manufacturers may face pressure to innovate less irritating adhesive technologies. Insurance policies may need adjustment to cover skin complication management.